Lupin
Dharmender Singh has extensive experience in sales and marketing within the oncology sector. Currently serving as GM Sales and Marketing Oncology at Lupin since August 2020, Dharmender previously held positions at Cipla Oncology from November 2016 onward, including Associate Director and Director of Sales and Marketing. Notably, Dharmender launched Cipla Oncology, which encompasses the Oncocare and Cytocare subdivisions, achieving a significant annual turnover of 35 crores. Earlier roles at Cipla include Group Product Manager for oncology products and Senior Product Manager for cardio diabetes, where key contributions included the establishment of a diabetic product line called Quadra. Dharmender began a career at Cipla as a Territory Manager shortly after joining as a management trainee. Dharmender holds an MSc in Zoology from Panjab University.
This person is not in any teams
This person is not in any offices
Lupin
15 followers
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments.